An illustration of two blue-hued T cells next to one another against a dark background. Regulatory T cells, or T regs, make up the basis for a slew of biotech companies working to treat immunological ...
IRF5 program strengthens Kymera’s oral immunology pipeline with a complementary mechanism to expand into rheumatic and other autoimmune diseases with a potential best-in-class oral drug IRF5, a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results